Suzuki K - Search Results

1

Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients.

Matsumoto M, Suzuki K, Kuroda J, Taniwaki M, Sunami K, Kosugi H, Ando K, Maruyama D, Tobinai K, Kher U, Farooqui M, Liao J, Marinello P, Matsuda K, Koh Y, Shimamoto T, Iida S. Matsumoto M, et al. Among authors: suzuki k. Int J Hematol. 2021 Jun;113(6):777-784. doi: 10.1007/s12185-021-03139-1. Epub 2021 Apr 15. Int J Hematol. 2021. PMID: 33856638 Clinical Trial.

2

Clinical implications of abnormalities of chromosomes 1 and 13 in multiple myeloma.

Nakagawa Y, Sawanobori M, Amaya H, Matsuda I, Inoue Y, Suzuki K, Hashimoto S, Kanno K. Nakagawa Y, et al. Among authors: suzuki k. Acta Haematol. 2003;109(3):129-36. doi: 10.1159/000069287. Acta Haematol. 2003. PMID: 12714822

3

[Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].

Matsuda I, Mori Y, Nakagawa Y, Sawanobori M, Uemura N, Suzuki K. Matsuda I, et al. Among authors: suzuki k. Rinsho Ketsueki. 2005 Dec;46(12):1293-7. Rinsho Ketsueki. 2005. PMID: 16447802 Japanese.

4

Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.

Abe Y, Muto M, Nieda M, Nakagawa Y, Nicol A, Kaneko T, Goto S, Yokokawa K, Suzuki K. Abe Y, et al. Among authors: suzuki k. Exp Hematol. 2009 Aug;37(8):956-68. doi: 10.1016/j.exphem.2009.04.008. Epub 2009 May 4. Exp Hematol. 2009. PMID: 19409955 Free article. Clinical Trial.

5

Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases: a multi-institutional study.

Nakagawa Y, Suzuki K, Hirose T, Chou T, Fujisawa S, Kida M, Usuki K, Ishida Y, Taniguchi S, Kouzai Y, Tomoyasu S, Miyazaki K, Higashihara M, Ando K, Aoki S, Arai A, Akiyama N, Hatake K, Okamoto S, Dan K, Ohyashiki K, Urabe A. Nakagawa Y, et al. Among authors: suzuki k. J Infect Chemother. 2011 Feb;17(1):58-67. doi: 10.1007/s10156-010-0075-3. Epub 2010 Jul 3. J Infect Chemother. 2011. PMID: 20602137 Clinical Trial.

6

Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.

Matsuda A, Taniwaki M, Jinnai I, Harada H, Watanabe M, Suzuki K, Yanagita S, Suzuki T, Yoshida Y, Kimura A, Tsudo M, Tohyama K, Takatoku M, Ozawa K. Matsuda A, et al. Among authors: suzuki k, suzuki t. Leuk Res. 2012 May;36(5):575-80. doi: 10.1016/j.leukres.2011.11.011. Epub 2011 Dec 15. Leuk Res. 2012. PMID: 22172461

7

Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.

Ogawa Y, Suzuki K, Sakai A, Iida S, Ogura M, Tobinai K, Matsumoto M, Matsue K, Terui Y, Ohashi K, Ishii M, Mukai HY, Ando K, Hotta T. Ogawa Y, et al. Among authors: suzuki k. Cancer Sci. 2013 Jul;104(7):912-9. doi: 10.1111/cas.12172. Epub 2013 May 27. Cancer Sci. 2013. PMID: 23574271 Free PMC article. Clinical Trial.

8

[Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].

Hamano A, Shingaki S, Abe Y, Miyazaki K, Sekine R, Nakagawa Y, Tsukada N, Hattori Y, Suzuki K. Hamano A, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 Apr;55(4):428-35. Rinsho Ketsueki. 2014. PMID: 24850453 Japanese.

9

[Effective control of skin reaction by air sandwich technique in a patient with IgE-κ myeloma treated with subcutaneous bortezomib injection].

Honda Y, Inoue J, Shingaki S, Miyazaki K, Abe Y, Sekine E, Iki S, Tsukada N, Suzuki K. Honda Y, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 May;55(5):570-2. Rinsho Ketsueki. 2014. PMID: 24881924 Japanese.

10

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma.

Suzuki K, Ogura M, Abe Y, Suzuki T, Tobinai K, Ando K, Taniwaki M, Maruyama D, Kojima M, Kuroda J, Achira M, Iizuka K. Suzuki K, et al. Among authors: suzuki t. Int J Hematol. 2015 Mar;101(3):286-94. doi: 10.1007/s12185-015-1743-y. Epub 2015 Feb 6. Int J Hematol. 2015. PMID: 25655379 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,742 results

Search Page

Filters